Both in Pharmaceuticals
Enveric Biosciences vs Alzamend Neuro
Over the past year ENVB returned −79.4% and ALZN returned −49.6%; their daily moves had a correlation of 0.02.
ENVB −79.4% ALZN −49.6%Growth of $1, one year, split-adjusted
| Metric | ENVB | ALZN |
|---|---|---|
| Price | $1.47 | $1.19 |
| Market cap | $6.6M | $5.7M |
| Today | +3.52% | +5.31% |
| 1 month | +1.4% | −34.6% |
| 6 months | −71.5% | +12.3% |
| Year to date | −59.5% | −34.6% |
| 1 year | −80.1% | −51.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $8.3M | $7.6M |
| Dividend yield | — | — |
| Volatility (60d) | 49.7% | 77.0% |
| Short % of float | 1.1% | 0.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).